- This event has passed.
Presenter(s): Gavin Bart, MD, PhD, Director, Division of Addiction Medicine at Hennepin Healthcare; Minneapolis, MN, Professor, Medical Discovery Team on Addiction at the University of Minnesota; Melodie Isgro, MD, Psychiatrist, Southcentral Foundation - a Tribal Health Organization; Anchorage, AK; Annie Potter, MSN, MPH, NP, CARN-AP, Clinical Educator, Office Based Addiction Treatment Program at Boston Medical Center and Boston University School of Medicine
Facilitator: Sherry Larkins, PhD, Director of International Programs and Research Sociologist, Integrated Substance Abuse Programs at the University of California, Los Angeles – Semel Institute for Neuroscience and Human Behavior
Cost: No fee
Target Audience: This activity was developed to meet the needs of physicians and all interprofessional healthcare providers.
Credit Designations Available: AMA PRA Category 1 Credit™, and Interprofessional Continuing Education (IPCE) credit.
Webinar Description: After the organizational and clinical components of initiating OUD treatment have been mapped out, how do we begin effective implementation? This session will review steps for conducting a small pilot/demonstration buprenorphine project, with regular outcomes-monitoring to ensure a smooth scale up of treatment and care for patients with OUD. We will discuss approaches for utilizing leadership and staff check-ins to get a pulse on practices, scale up, and changes needed to ensure successful expansion across all administrative and clinical staff.
- Summarize how to assess fidelity and adherence to protocols
- Interpret outcomes and indicators to improve processes and practices
Continuing Education Information:
In support of improving patient care, this activity has been planned and implemented by Addiction Technology Transfer Center Network and American Academy of Addiction Psychiatry. American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Interprofessional Continuing Education (IPCE) Designation Statement:
This activity was planned by and for the healthcare team, and learners will receive 1 (one) Interprofessional Continuing Education credits for learning and change.
Physician Designation Statement
American Academy of Addiction Psychiatry designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Health Professionals
Participants will receive a Certificate of Attendance stating this program is designated for 1.0 hour AMA PRA Category 1 Credit™. This credit is accepted by the AANP and the AAPA.